In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 65 for your search:
Cancer Type/Condition:  Breast cancer, female
Stage/Subtype:  breast cancer in situ
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-979254, NCI-P98-0135
2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 26 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067020, RTOG-9804, CAN-NCIC-MA26, CALGB-49801, RTOG-DEV-1026, MA26, NCT00003857
3.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069015, E-2193, NCI-P01-0194, ECOG-E2193, NCT00026286
4.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069217, NCCTG-N99C7, NCI-P02-0204, NCT00030914
5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NSABP-B-17, CLB-8793, MAOP-1285, NCOG-NSABP-B-17
6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: pre/postmenopausal
Sponsor: NCI
Protocol IDs: NSABP-B-24
7.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000530309, NCCTG-N06C4, N06C4, NCT00438659
8.

Phase: Phase III
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065314, CALGB-49901, S9630, U10CA037429, U10CA032102, SWOG-S9630, SWOG-9630, NCT00002920
9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: NSABP B-35, SWOG-NSABP-B-35, NCCTG-NSABP-B-35, ACOSOG-NSABP-B-35, NCT00053898
10.

Phase: Phase II
Type: Natural history/Epidemiology
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065370, U10CA021115, E-5194, NCT00002934
11.

Phase: Phase II
Type: Prevention
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: ID94-029, P30CA016672, MDA-ID-94029, NCI-P97-0113, CDR0000065829, NCT00003099
12.

Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-99017, NCI-G99-1662, NCT00004247
13.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: Postmenopausal (20 and over)
Sponsor: NCI, Other
Protocol IDs: CDR0000069219, U10CA076001, CALGB-79805, NCI-P02-0206, NCT00031720
14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ICC4102, P30CA043703, CWRU-ICC-4102, NCT00054301
15.

Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: CNR-IEO-007, U01-CA77188-01
16.

Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: 040044, 04-C-0044, NCT00073073
17.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 35 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000375585, DFCI-00024, UCLA-0210012-02, NCT00090857
18.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 45 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000428460, P30CA016042, UCLA-0410033-01, NCT00112749
19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: J0365 CDR0000446285, P30CA006973, JHOC-J0365, JHOC-SKCCC-J0365, JHOC-IRB-03100706, NCT00244959
20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J0485, CDR0000477214, P50CA088843, P30CA006973, JHOC-J0485, JHOC-SKCCC-J0485, JHOC-04100404, J0485, NCT00334542
21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Closed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: J05100, CDR0000485361, P30CA006973, JHOC-J05100, JHOC-SKCCC-J05100, J05100, NCT00354640
22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000522934, UCSF-047522, UCSF-H8409-26206-01, MSKCC-06041, NCT00416403
23.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000579010, P30CA015083, MC06C8, 06-005157, MAYO-MC06C8, NCT00569166
24.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CASE11107, P30CA043703, CASE-11107-CC479, NCT00945061
25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000634111, R21CA132236, P30CA069533, OHSU-4702, eIRB 4702, OHSU-LAY-01, NCT00843167
1    
New Search